Meatable
Meatable is a Dutch biotechnology company aimed at cultured meat, particularly pork. HistoryMeatable was co-founded by Krijn de Nood, Daan Luining, and Mark Kotter in 2018.[1][2] It began operating on the campus of Delft University of Technology.[3] and by 2018 reported it had succeeded growing meat using pluripotent stem cells from animal umbilical cords.[4] becoming one of the first start-ups to eliminate fetal bovine serum.[5] On 26 September 2018, Luining represented Meatable at a round table discussion on cultured meat in the Dutch House of Representatives.[6] In early October 2018, Meatable attracted 3.5 million euros in funding from investors.[7] Meatable presented at the Consumer Electronics Show (CES) in Las Vegas in January 2020,[3] stating that it sought to present proof of concept by the end of the year.[8] By then, Meatable was working with scientists from Cambridge and Stanford to produce a hamburger within three weeks from a single stem cell via a process the company had patented.[3] In 2021, Meatable obtained funding from various investors worth 40 million euros (47 million US dollars).[1] Its total capital at the time was approximately 53 million euros (60 million US dollars).[2] By April 2021, the staff of Meatable had grown to over 40 people with 15 different nationalities, representing many different fields and coming from many universities.[2] The same year, Meatable announced that it had entered into an agreement with DSM in order to 'make cultured meat affordable and accessible on a large scale.'[9] In April 2024, Meatable was the first company in the European Union to receive regulatory approval from the EFSA for a public tasting of cultured meat, in this case sausage, amid much international and national media attention.[10][11][12] References
External links |